
According to a report from Watchlistnews, American investment firm Ninety One North America Inc. has reduced its investment in Philip Morris International Inc. stocks by 12.0%.
After selling 84,538 shares, Ninety-One North America Corporation now owns only 620,984 shares of the company. Philip Morris International accounts for 2.8% of Ninety-One North America Corporation's investment portfolio, ranking as its 15th largest investment. As of the latest filing with the Securities and Exchange Commission (SEC), Ninety-One North America Corporation's investment value in Philip Morris International is $57,491,000.
Philip Morris International is a tobacco company that focuses on providing a smoke-free environment for the future. Its product portfolio includes not only tobacco and nicotine products but also non-tobacco alternatives. The company's product lineup primarily consists of cigarettes and smoke-free products, including heated tobacco, e-cigarettes, and oral nicotine products. Its main brands are IQOS and ZYN, along with consumer accessories such as lighters and matches.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com